Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
37 studies found for:    "Genital Diseases, Female" | Mexico
Show Display Options
Rank Status Study
1 Terminated
Has Results
A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Ixabepilone;   Drug: Doxorubicin;   Drug: Paclitaxel
2 Completed Implementation of an Efficacious Intervention for High Risk Women in Mexico
Conditions: HIV;   Syphilis;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Mujer Segura;   Behavioral: CENSIDA counseling program
3 Active, not recruiting TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cancer
Interventions: Drug: AMG 386;   Drug: AMG 386 Placebo;   Drug: Paclitaxel
4 Recruiting Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Paclitaxel
5 Recruiting Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received at Least 2 Prior Platinum Treatments.
Condition: Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
Interventions: Drug: OLAPARIB;   Drug: Single agent chemotherapy
6 Completed
Has Results
A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Paclitaxel;   Drug: Bevacizumab;   Drug: Carboplatin
7 Completed Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
Condition: Ovarian Cancer
Interventions: Drug: MORAb-003 (farletuzumab);   Drug: 0.9% Saline
8 Completed
Has Results
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
Condition: Menorrhagia
Interventions: Drug: Levonorgestrel IUS (Mirena, BAY86-5028);   Drug: Medroxyprogesterone acetate
9 Completed
Has Results
A Study to Compare Efficacy and Safety of an Ovule Containing Terconazole, Clindamycin and Fluocinolone Versus an Ovule Containing Metronidazole, Nystatin and Fluocinolone in the Treatment of Secondary Vulvar/ or Vaginal Symptoms of Infectious Vaginitis/ and Infectious Vaginosis
Conditions: Vaginitis;   Infectious Vaginosis
Interventions: Drug: Gynoclin V;   Drug: Vagitrol V
10 Recruiting Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Metformin;   Dietary Supplement: Magnesium;   Dietary Supplement: PUFA
11 Recruiting Triage Strategies in Cervical Cancer Prevention
Conditions: Cervical Cancer;   Intraepithelial Neoplasia
Intervention: Other: HPV screening and triage tests
12 Not yet recruiting Texting Intervention to Sustain HIV Prevention in Women in High-drug-use Contexts
Conditions: HIV;   Syphilis;   Gonorrhea;   Chlamydia
Interventions: Behavioral: Mujer Segura Siempre;   Behavioral: General Health Message Texts
13 Not yet recruiting Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
Condition: Cervical Cancer
Interventions: Drug: Hydralazine/Magnesium;   Drug: Placebo;   Drug: Carboplatin;   Drug: Paclitaxel
14 Recruiting Sonography Guided Transcervical Ablation of Uterine Fibroids
Condition: Menorrhagia
Intervention: Device: Intrauterine Ultrasound-Guided Radiofrequency Ablation System
15 Completed A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
Condition: Uterine Cervical Cancer
Interventions: Drug: Nimotuzumab;   Drug: Cisplatin;   Drug: Gemcitabine;   Procedure: CT Scan
16 Completed Combination of Nimotuzumab Cisplatin-Vinorelbine in First Line Chemotherapy in Recurring-Persistent Cervical Carcinoma
Conditions: Cervical Cancer Recurrent or Persistent;   Palliative Treatment;   Monoclonal Antibody in Cervical Cancer Treatment
Interventions: Drug: mAb Nimotuzumab;   Device: Placebo
17 Completed
Has Results
A Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System
Condition: Menorrhagia Due to Benign Causes
Intervention: Device: Aurora Endometrial Ablation System
18 Active, not recruiting Safety & Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding
Condition: Menorrhagia
Intervention: Device: AEGEA Vapor System(TM)
19 Recruiting Cervical Cancer Screening With Human Papillomavirus Testing
Conditions: CIN3;   CIN2;   Cervical Cancer
Intervention: Other: HPV screening
20 Completed Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women
Conditions: Pregestational Obesity (BMI > 27kg/m2);   History of Polycystic Ovary Syndrome
Interventions: Drug: medical nutrition therapy + metformin;   Behavioral: Medical nutrition therapy

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years